Published in J Am Coll Cardiol on April 19, 2011
Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat Rev Cardiol (2013) 2.09
Evaluating pathogenicity of rare variants from dilated cardiomyopathy in the exome era. Circ Cardiovasc Genet (2012) 1.78
A novel human R25C-phospholamban mutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia. Cardiovasc Res (2015) 1.46
Interpreting secondary cardiac disease variants in an exome cohort. Circ Cardiovasc Genet (2013) 1.43
Autosomal recessive dilated cardiomyopathy due to DOLK mutations results from abnormal dystroglycan O-mannosylation. PLoS Genet (2011) 1.36
Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Med (2016) 1.35
Genetic testing for dilated cardiomyopathy in clinical practice. J Card Fail (2012) 1.32
Exome sequencing and genome-wide linkage analysis in 17 families illustrate the complex contribution of TTN truncating variants to dilated cardiomyopathy. Circ Cardiovasc Genet (2013) 1.30
Doubly heterozygous LMNA and TTN mutations revealed by exome sequencing in a severe form of dilated cardiomyopathy. Eur J Hum Genet (2013) 1.00
Contemporary strategies in the diagnosis and management of heart failure. Mayo Clin Proc (2014) 0.98
Genetics and epigenetics of arrhythmia and heart failure. Front Genet (2013) 0.94
RAF1 mutations in childhood-onset dilated cardiomyopathy. Nat Genet (2014) 0.93
Antisense-mediated exon skipping: a therapeutic strategy for titin-based dilated cardiomyopathy. EMBO Mol Med (2015) 0.93
Genetics and disease of ventricular muscle. Cold Spring Harb Perspect Med (2014) 0.92
Cardiac disease and arrhythmogenesis: Mechanistic insights from mouse models. Int J Cardiol Heart Vasc (2016) 0.90
New Genetic Insights into Congenital Heart Disease. J Clin Exp Cardiolog (2012) 0.89
Biophysics, pathophysiology, and pharmacology of ion channel gating pores. Front Pharmacol (2014) 0.87
Clinical utility gene card for: dilated cardiomyopathy (CMD). Eur J Hum Genet (2012) 0.87
The BAG3 gene variants in Polish patients with dilated cardiomyopathy: four novel mutations and a genotype-phenotype correlation. J Transl Med (2014) 0.86
The mutations associated with dilated cardiomyopathy. Biochem Res Int (2012) 0.86
Temporal relationship of conduction system disease and ventricular dysfunction in LMNA cardiomyopathy. J Card Fail (2013) 0.86
Cell-cell junction remodeling in the heart: possible role in cardiac conduction system function and arrhythmias? Life Sci (2011) 0.85
Exome sequencing establishes diagnosis of Alström syndrome in an infant presenting with non-syndromic dilated cardiomyopathy. Am J Med Genet A (2015) 0.84
Cardiac disease modeling using induced pluripotent stem cell-derived human cardiomyocytes. World J Stem Cells (2015) 0.83
Targeted next-generation sequencing of candidate genes reveals novel mutations in patients with dilated cardiomyopathy. Int J Mol Med (2015) 0.83
Return of genetic results in the familial dilated cardiomyopathy research project. J Genet Couns (2012) 0.81
Comparison of echocardiographic and cardiac magnetic resonance imaging in hypertrophic cardiomyopathy sarcomere mutation carriers without left ventricular hypertrophy. Circ Cardiovasc Genet (2013) 0.81
Dilated cardiomyopathy. Circ Arrhythm Electrophysiol (2012) 0.81
Short read (next-generation) sequencing: a tutorial with cardiomyopathy diagnostics as an exemplar. Circ Cardiovasc Genet (2013) 0.80
Importance of genetic evaluation and testing in pediatric cardiomyopathy. World J Cardiol (2014) 0.80
DCM-related tropomyosin mutants E40K/E54K over-inhibit the actomyosin interaction and lead to a decrease in the number of cycling cross-bridges. PLoS One (2012) 0.80
Genetics and heart failure: a concise guide for the clinician. Curr Cardiol Rev (2015) 0.78
Familial dilated cardiomyopathy: Current challenges and future directions. Glob Cardiol Sci Pract (2012) 0.78
Next-generation sequencing: from understanding biology to personalized medicine. Biology (Basel) (2013) 0.78
Whole exome sequencing identifies a novel EMD mutation in a Chinese family with dilated cardiomyopathy. BMC Med Genet (2014) 0.77
Heart failure: advanced development in genetics and epigenetics. Biomed Res Int (2015) 0.77
Familial Dilated Cardiomyopathy Caused by a Novel Frameshift in the BAG3 Gene. PLoS One (2016) 0.77
Modeling structural and functional deficiencies of RBM20 familial dilated cardiomyopathy using human induced pluripotent stem cells. Hum Mol Genet (2015) 0.77
Localization of the binding interface between leiomodin-2 and α-tropomyosin. Biochim Biophys Acta (2016) 0.77
A low prevalence of sarcomeric gene variants in a Chinese cohort with left ventricular non-compaction. Heart Vessels (2014) 0.76
A Haplotype of Two Novel Polymorphisms in δ-Sarcoglycan Gene Increases Risk of Dilated Cardiomyopathy in Mongoloid Population. PLoS One (2015) 0.76
Screening first-degree relatives of patients with idiopathic dilated cardiomyopathy. Herz (2016) 0.75
Cardiac troponin T (TNNT2) mutations in chinese dilated cardiomyopathy patients. Biomed Res Int (2014) 0.75
Dilated cardiomyopathy produced by lamin A/C gene mutations. Clujul Med (2013) 0.75
Assessment of LMNA copy number variation in 58 probands with dilated cardiomyopathy. Clin Transl Sci (2011) 0.75
Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Afford New Opportunities in Inherited Cardiovascular Disease Modeling. Cardiol Res Pract (2016) 0.75
Periodontitis in Chronic Heart Failure. Tex Heart Inst J (2016) 0.75
Familial dilated cardiomyopathy diagnosis is commonly overlooked at the time of transplant listing. J Heart Lung Transplant (2015) 0.75
An uncommon clinical presentation of relapsing dilated cardiomyopathy with identification of sequence variations in MYNPC3, KCNH2 and mitochondrial tRNA cysteine. Mol Genet Metab Rep (2015) 0.75
Sudden cardiac death diagnosed with dilated cardiomyopathy in a Kuwaiti family: a case report. BMC Res Notes (2014) 0.75
Using genetic testing to guide therapeutic decisions in cardiomyopathy. Curr Treat Options Cardiovasc Med (2013) 0.75
Inpatient detection of cardiac-inherited disease: the impact of improving family history taking. Open Heart (2016) 0.75
A novel c.563 T>G, p.L189R lamin A/C mutation in identical twins with dilated cardiomyopathy. Korean J Intern Med (2016) 0.75
Diagnosis, prevalence, and screening of familial dilated cardiomyopathy. Expert Opin Orphan Drugs (2015) 0.75
Personalizing Risk Stratification for Sudden Death in Dilated Cardiomyopathy: The Past, Present, and Future. Circulation (2017) 0.75
Targeted next-generation sequencing detects novel gene-phenotype associations and expands the mutational spectrum in cardiomyopathies. PLoS One (2017) 0.75
ALPK3 gene mutation in a patient with congenital cardiomyopathy and dysmorphic features. Cold Spring Harb Mol Case Stud (2017) 0.75
Differences in Presentation and Outcomes Between Children With Familial Dilated Cardiomyopathy and Children With Idiopathic Dilated Cardiomyopathy: A Report From the Pediatric Cardiomyopathy Registry Study Group. Circ Heart Fail (2017) 0.75
Targeted capture and massively parallel sequencing of 12 human exomes. Nature (2009) 33.96
Exome sequencing identifies the cause of a mendelian disorder. Nat Genet (2009) 32.06
Distribution and intensity of constraint in mammalian genomic sequence. Genome Res (2005) 18.85
Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. N Engl J Med (2010) 13.57
Most rare missense alleles are deleterious in humans: implications for complex disease and association studies. Am J Hum Genet (2007) 10.92
ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007. Genet Med (2008) 9.13
Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation (2003) 5.85
1000 Genomes project. Nat Biotechnol (2008) 5.73
Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med (1999) 5.61
The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell (2002) 4.72
Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N Engl J Med (1993) 4.36
Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med (2000) 4.30
Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm (2005) 4.21
Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA (2005) 3.89
Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science (2003) 3.71
A novel X-linked gene, G4.5. is responsible for Barth syndrome. Nat Genet (1996) 3.58
Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline. J Card Fail (2009) 3.54
The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med (1992) 3.53
Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J Am Coll Cardiol (2004) 3.47
Clinical and genetic issues in familial dilated cardiomyopathy. J Am Coll Cardiol (2005) 3.42
Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science (1998) 3.22
Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. J Am Coll Cardiol (2003) 3.20
SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. Circulation (2004) 3.01
ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating. Nat Genet (2004) 2.85
Genetic causes of human heart failure. J Clin Invest (2005) 2.79
Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol (1998) 2.73
Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat Genet (2002) 2.67
Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation (1999) 2.59
Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. J Clin Invest (2003) 2.56
Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy. Am Heart J (2008) 2.48
Exome sequencing of a multigenerational human pedigree. PLoS One (2009) 2.48
Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J Am Coll Cardiol (2003) 2.47
Mutations in the muscle LIM protein and alpha-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis. Mol Genet Metab (2003) 2.42
Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy. Circulation (2010) 2.41
Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol (2004) 2.40
Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. Circulation (2000) 2.32
Evolutionary constraint facilitates interpretation of genetic variation in resequenced human genomes. Genome Res (2010) 2.31
X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation (1993) 2.30
Alpha B-crystallin mutation in dilated cardiomyopathy. Biochem Biophys Res Commun (2006) 2.27
Dilated cardiomyopathy. Lancet (2010) 2.24
Coding sequence mutations identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 patients with familial or idiopathic dilated cardiomyopathy. Clin Transl Sci (2008) 2.17
Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease. J Am Coll Cardiol (2002) 2.15
Mutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain gene. Eur Heart J (2005) 2.07
Identification of a novel frameshift mutation in the giant muscle filament titin in a large Australian family with dilated cardiomyopathy. J Mol Med (Berl) (2006) 2.05
Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling. J Med Genet (2005) 2.04
Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease. J Am Coll Cardiol (1998) 2.03
Multiple mutations in desmosomal proteins encoding genes in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart Rhythm (2009) 2.00
Coding sequence rare variants identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 from 312 patients with familial or idiopathic dilated cardiomyopathy. Circ Cardiovasc Genet (2010) 1.98
Metavinculin mutations alter actin interaction in dilated cardiomyopathy. Circulation (2002) 1.95
Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy. J Mol Cell Cardiol (2001) 1.92
Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Invest (2000) 1.91
Clinical and genetic issues in dilated cardiomyopathy: a review for genetics professionals. Genet Med (2010) 1.90
Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy. J Am Coll Cardiol (2010) 1.83
Identification and functional characterization of cardiac troponin I as a novel disease gene in autosomal dominant dilated cardiomyopathy. Circ Res (2009) 1.83
Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations. J Am Coll Cardiol (2010) 1.80
Mutation in the transcriptional coactivator EYA4 causes dilated cardiomyopathy and sensorineural hearing loss. Nat Genet (2005) 1.80
Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy. J Am Coll Cardiol (2004) 1.79
The genetics of dilated cardiomyopathy. Curr Opin Cardiol (2010) 1.76
Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Heart Fail (2009) 1.74
A novel lamin A/C mutation in a family with dilated cardiomyopathy, prominent conduction system disease, and need for permanent pacemaker implantation. Am Heart J (2002) 1.71
Epidemiology of desmin and cardiac actin gene mutations in a european population of dilated cardiomyopathy. Eur Heart J (2000) 1.68
Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy. Circulation (2005) 1.67
Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy. Circulation (2010) 1.67
Mutations of presenilin genes in dilated cardiomyopathy and heart failure. Am J Hum Genet (2006) 1.63
Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol (2010) 1.62
Mutations in PDLIM3 and MYOZ1 encoding myocyte Z line proteins are infrequently found in idiopathic dilated cardiomyopathy. Mol Genet Metab (2007) 1.60
High incidence of sudden death with conduction system and myocardial disease due to lamins A and C gene mutation. Pacing Clin Electrophysiol (2000) 1.58
Laminin-alpha4 and integrin-linked kinase mutations cause human cardiomyopathy via simultaneous defects in cardiomyocytes and endothelial cells. Circulation (2007) 1.57
Novel mutations in sarcomeric protein genes in dilated cardiomyopathy. Biochem Biophys Res Commun (2002) 1.55
Genetics of dilated cardiomyopathy. Ann Med (2007) 1.52
Malignant and benign mutations in familial cardiomyopathies: insights into mutations linked to complex cardiovascular phenotypes. J Mol Cell Cardiol (2010) 1.47
Reviews of translational medicine and genomics in cardiovascular disease: new disease taxonomy and therapeutic implications cardiomyopathies: therapeutics based on molecular phenotype. J Am Coll Cardiol (2007) 1.42
Novel mutation in cardiac troponin I in recessive idiopathic dilated cardiomyopathy. Lancet (2004) 1.38
The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies. Am J Hum Genet (1997) 1.37
Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy. Hum Mutat (2005) 1.37
Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations. J Med Genet (2003) 1.37
Prevalence of desmin mutations in dilated cardiomyopathy. Circulation (2007) 1.28
Novel lamin A/C mutations in two families with dilated cardiomyopathy and conduction system disease. J Card Fail (2001) 1.27
Mutations in the Z-band protein myopalladin gene and idiopathic dilated cardiomyopathy. Cardiovasc Res (2007) 1.21
Mutations in the ANKRD1 gene encoding CARP are responsible for human dilated cardiomyopathy. Eur Heart J (2009) 1.19
Multiple mutations in genetic cardiovascular disease: a marker of disease severity? Circ Cardiovasc Genet (2009) 1.18
The role of sarcomere gene mutations in patients with idiopathic dilated cardiomyopathy. Eur J Hum Genet (2009) 1.15
Cardiomyopathy, familial dilated. Orphanet J Rare Dis (2006) 1.14
Novel mutations in the lamin A/C gene in heart transplant recipients with end stage dilated cardiomyopathy. Heart (2006) 1.12
Novel cardiac troponin T mutation as a cause of familial dilated cardiomyopathy. Circulation (2001) 1.12
Prevalence of desmosomal protein gene mutations in patients with dilated cardiomyopathy. Circ Cardiovasc Genet (2010) 1.10
Genetic testing in cardiovascular disease. J Am Coll Cardiol (2007) 1.10
Genetics of dilated cardiomyopathy. Heart Fail Clin (2010) 1.08
Defining the pathogenicity of DNA sequence variation. Circ Cardiovasc Genet (2009) 1.07
In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients. J Med Genet (2005) 1.07
Phospholamban R14 deletion results in late-onset, mild, hereditary dilated cardiomyopathy. J Am Coll Cardiol (2006) 1.04
Use of genetics in the clinical evaluation of cardiomyopathy. JAMA (2009) 1.01
Cardiac troponin T lysine 210 deletion in a family with dilated cardiomyopathy. J Card Fail (2002) 0.98
Lamin A/C truncation in dilated cardiomyopathy with conduction disease. BMC Med Genet (2003) 0.96
Genetic evaluation of familial cardiomyopathy. J Cardiovasc Transl Res (2008) 0.95
Mutational screening of phospholamban gene in hypertrophic and idiopathic dilated cardiomyopathy and functional study of the PLN -42 C>G mutation. Eur J Heart Fail (2006) 0.93
LMNA mutations in cardiac transplant recipients. Cardiology (2004) 0.93
A novel mutation, Arg71Thr, in the delta-sarcoglycan gene is associated with dilated cardiomyopathy. J Mol Med (Berl) (2003) 0.92
Guidelines for the diagnosis and management of familial dilated cardiomyopathy. Heart Lung Circ (2006) 0.90
Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy. Am J Hum Genet (2011) 2.38
Coding sequence rare variants identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 from 312 patients with familial or idiopathic dilated cardiomyopathy. Circ Cardiovasc Genet (2010) 1.98
Clinical and genetic issues in dilated cardiomyopathy: a review for genetics professionals. Genet Med (2010) 1.90
Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Heart Fail (2009) 1.74
Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy. Circulation (2010) 1.67
Identification of novel mutations in RBM20 in patients with dilated cardiomyopathy. Clin Transl Sci (2010) 1.52
The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families. Cancer Res (2008) 1.24
SCN5A rare variants in familial dilated cardiomyopathy decrease peak sodium current depending on the common polymorphism H558R and common splice variant Q1077del. Clin Transl Sci (2010) 1.07
Rare variant mutations identified in pediatric patients with dilated cardiomyopathy. Prog Pediatr Cardiol (2011) 0.95
Functional characterization of TNNC1 rare variants identified in dilated cardiomyopathy. J Biol Chem (2011) 0.92
Temporal relationship of conduction system disease and ventricular dysfunction in LMNA cardiomyopathy. J Card Fail (2013) 0.86
Late onset sporadic dilated cardiomyopathy caused by a cardiac troponin T mutation. Clin Transl Sci (2010) 0.81
Assessment of LMNA copy number variation in 58 probands with dilated cardiomyopathy. Clin Transl Sci (2011) 0.75